Role of MeCP2 in neurological disorders: current status and future perspectives

Trichostatin A decreases the levels of MeCP2 expression and phosphorylation and increases its chromatin binding affinity

(2017) Katrina V. Good et al.   Epigenetics

Asperger syndrome and early-onset schizophrenia associated with a novel MECP2 deleterious missense variant

(2017) Aurore Curie et al.   PSYCHIATRIC GENETICS

An RNA interference screen identifies druggable regulators of MeCP2 stability

(2017) Laura M. Lombardi et al.   Science Translational Medicine

m 6 A in mRNA: An Ancient Mechanism for Fine-Tuning Gene Expression

(2017) Jean-Yves Roignant et al.   TRENDS IN GENETICS

MeCP2 mutations: progress towards understanding and treating Rett syndrome

(2017) Ruth R. Shah et al.   Genome Medicine

Rett Syndrome and the Ongoing Legacy of Close Clinical Observation

(2016) Huda Y. Zoghbi   CELL

Enrichment of mutations in chromatin regulators in people with Rett syndrome lacking mutations in MECP2

(2016) Samin A. Sajan et al.   GENETICS IN MEDICINE

Epigenetic Determinants of Cancer

(2016) Stephen B. Baylin et al.   Cold Spring Harbor Perspectives in Biology

MeCP2 and the enigmatic organization of brain chromatin. Implications for depression and cocaine addiction

(2016) Juan Ausió   Clinical Epigenetics

Disruption of DNA-methylation-dependent long gene repression in Rett syndrome

(2015) Harrison W. Gabel et al.   NATURE

The extended AT-hook is a novel RNA binding motif

(2015) Michael Filarsky et al.   RNA Biology

MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in Malignancy

(2015) M. Neupane et al.   Cancer Discovery

Circadian Cycle-Dependent MeCP2 and Brain Chromatin Changes

(2015) Alexia Martínez de Paz et al.   PLoS One

MeCP2: the long trip from a chromatin protein to neurological disorders

(2014) Juan Ausió et al.   TRENDS IN MOLECULAR MEDICINE

MeCP2 post-translational modifications: a mechanism to control its involvement in synaptic plasticity and homeostasis?

(2014) Elisa Bellini et al.   Frontiers in Cellular Neuroscience

Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor

(2013) Matthew J Lyst et al.   NATURE NEUROSCIENCE

Chromatin context and ncRNA highlight targets of MeCP2 in brain

(2013) Scott S Maxwell et al.   RNA Biology

MeCP2 post-translational regulation through PEST domains: two novel hypotheses

(2009) Anita A. Thambirajah et al.   BIOESSAYS